Cargando…

Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease

INTRODUCTION: Cryptococcal meningitis (CM) is an opportunistic fungal disease with a high mortality among HIV-positive patients with severe immunosuppression (CD4 count <100 cells/μl). Reflexed screening for cryptococcal antigen (CrAg) in remnant blood samples was initially piloted at selected CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coetzee, Lindi-Marie, Cassim, Naseem, Sriruttan, Charlotte, Mhlanga, Mabatho, Govender, Nelesh P., Glencross, Deborah Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997320/ https://www.ncbi.nlm.nih.gov/pubmed/29894509 http://dx.doi.org/10.1371/journal.pone.0198993

Ejemplares similares

District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa
por: Cassim, Naseem, et al.
Publicado: (2018)

Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa
por: Cassim, Naseem, et al.
Publicado: (2017)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa
por: Larson, Bruce A., et al.
Publicado: (2016)

Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals
por: Cassim, Naseem, et al.
Publicado: (2017)

Using laboratory data to assess the impact of coronavirus (COVID-19) on reflex cryptococcal antigenaemia (CrAg) testing in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

Estimating Implementation and Operational Costs of an Integrated Tiered CD4 Service including Laboratory and Point of Care Testing in a Remote Health District in South Africa
por: Cassim, Naseem, et al.
Publicado: (2014)

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa
por: Quan, Vanessa, et al.
Publicado: (2019)

An Integrated Tiered Service Delivery Model (ITSDM) Based on Local CD4 Testing Demands Can Improve Turn-Around Times and Save Costs whilst Ensuring Accessible and Scalable CD4 Services across a National Programme
por: Glencross, Deborah K., et al.
Publicado: (2014)

Using laboratory data to categorise CD4 laboratory turn-around-time performance across a national programme
por: Coetzee, Lindi-Marie, et al.
Publicado: (2018)

Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa
por: Cassim, Naseem, et al.
Publicado: (2020)

Weekly laboratory turn-around time identifies poor performance masked by aggregated reporting
por: Coetzee, Lindi-Marie, et al.
Publicado: (2020)

Newly implemented community CD4 service in Tshwaragano, Northern Cape province, South Africa, positively impacts result turn-around time
por: Coetzee, Lindi-Marie, et al.
Publicado: (2022)

Modelling CD4 reagent usage across a national hierarchal network of laboratories in South Africa
por: Cassim, Naseem, et al.
Publicado: (2023)

Compliance to HIV treatment monitoring guidelines can reduce laboratory costs
por: Cassim, Naseem, et al.
Publicado: (2016)

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach
por: Cassim, Naseem, et al.
Publicado: (2018)

Programmatic implications of implementing the relational algebraic capacitated location (RACL) algorithm outcomes on the allocation of laboratory sites, test volumes, platform distribution and space requirements
por: Cassim, Naseem, et al.
Publicado: (2017)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
por: Cassim, Naseem, et al.
Publicado: (2021)

Timely delivery of laboratory efficiency information, Part I: Developing an interactive turnaround time dashboard at a high-volume laboratory
por: Cassim, Naseem, et al.
Publicado: (2020)

Assessing CD4 rejections across a national laboratory service for 2018 in South Africa: highlighting the importance of adherence to national handbook guidelines
por: Cassim, Naseem, et al.
Publicado: (2022)

Multilocus sequence typing of azole-resistant Candida auris strains, South Africa
por: Magobo, Rindidzani, et al.
Publicado: (2020)

Timely delivery of laboratory efficiency information, Part II: Assessing the impact of a turn-around time dashboard at a high-volume laboratory
por: Cassim, Naseem, et al.
Publicado: (2020)

Performance verification of the new fully automated Aquios flow cytometer PanLeucogate (PLG) platform for CD4-T-lymphocyte enumeration in South Africa
por: Coetzee, Lindi-Marie, et al.
Publicado: (2017)

Candida auris in South Africa, 2012–2016
por: Govender, Nelesh P., et al.
Publicado: (2018)

Performance Evaluation of the Becton Dickinson FACSPresto(™) Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa
por: Coetzee, Lindi-Marie, et al.
Publicado: (2016)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Cost of running a full-service receiving office at a centralised testing laboratory in South Africa
por: Cassim, Naseem, et al.
Publicado: (2022)

Prevalence and clinical presentation of Cryptococcal meningitis among HIV seropositive patients
por: Baradkar, Vasant, et al.
Publicado: (2009)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2021)

Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
por: Meiring, Susan, et al.
Publicado: (2016)

Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016
por: Cassim, Naseem, et al.
Publicado: (2022)

Using Systematized Nomenclature of Medicine clinical term codes to assign histological findings for prostate biopsies in the Gauteng province, South Africa: Lessons learnt
por: Cassim, Naseem, et al.
Publicado: (2020)

Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study
por: Longley, Nicky, et al.
Publicado: (2016)

Large Outbreaks of Fungal and Bacterial Bloodstream Infections in a Neonatal Unit, South Africa, 2012–2016
por: van Schalkwyk, Erika, et al.
Publicado: (2018)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Using text mining techniques to extract prostate cancer predictive information (Gleason score) from semi-structured narrative laboratory reports in the Gauteng province, South Africa
por: Cassim, Naseem, et al.
Publicado: (2021)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

100 and counting!
por: CERN Bulletin
Publicado: (2012)

Cryptococcus neoformans: Diagnostic Dilemmas, Electron Microscopy and Capsular Variants
por: Birkhead, Monica, et al.
Publicado: (2018)

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease
por: Wake, Rachel M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3r15978126f3m6pse3kcrn5omi